Merck KGaA
Merck KGaA (MKGAF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MKGAF · as of Jun 8, 2026
Key Statistics
Explore Merck KGaA Data
mkgaf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
mkgaf competitorsMKGAF
ARGNF
CHALF
CMXHF
DSKYF
DSNKYStock Performance
Full HistoryAbout Merck KGaA
Merck KGaA is a venerable science and technology enterprise, headquartered in Darmstadt, Germany, where it was established in 1668. Operating as a subsidiary of E. Merck KG, the company organizes its …
what is merck kgaa · mkgaf stock overview · merck kgaa company profile · who is merck kgaa ceo · mkgaf OTC · merck kgaa headquarters · merck kgaa business segments
About Stock Overview & Key Data
Merck KGaA (MKGAF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Aug 3, 2012. As of the latest trading session, MKGAF stock price is $159.71, with a market capitalization of $69.4B. The stock has returned +13.47% over the past 12 months and +5.07% year-to-date.
In fiscal year 2025, Merck KGaA reported revenue of $21.1B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Merck KGaA (MKGAF) stock price is $159.71. The stock is traded on OTC under the ticker symbol MKGAF. The 52-week range is $116.68 – $163.85.